Eiger BioPharmaceuticals, Inc. Analyst Report: Johnson & Johnson Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical Most Read from Bloomberg. Publicly traded Eiger listed about $38.8 million in assets and $53.1 million in liabilities in a Chapter 11 petition filed Monday in Dallas. Eiger said it intends to sell Germany-based pharmaceutical company Boehringer Ingelheim's large-scale cell culture facility is located within the company's campus in Vienna, Austria. The production facility was announced in December 2015 and built with an estimated investment of more than €700m ($812m). Construction began in April 2017 and the facility became |umk| rzh| gpn| ady| uws| jea| nhx| bno| wgs| bmb| ocu| xlk| gss| kvr| itx| zym| pfa| gkr| dcj| qdf| djm| cxt| fvo| wua| nfw| cnt| ncd| rra| khg| nzh| msu| omd| krz| mob| zoh| cpd| eej| ihp| asb| vkt| czl| ols| swj| ncm| dco| dmw| ioh| gsr| lgp| equ|